Chronic Myelogenous Leukemia Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000258006-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Chronic Myelogenous Leukemia Treatment
Laetrile/Amygdalin (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Questions and Answers About Laetrile / Amygdalin
What is laetrile? Laetrile is a compound that has been used as an anticancer treatment in humans worldwide. It is not approved by the US Food and Drug Administration (FDA) as a treatment for cancer or any other medical condition. The term "laetrile" comes from 2 words (laevorotatory and mandelonitrile) and is used to describe a purified form of the chemical amygdalin. Amygdalin is a plant ...
Nausea and Vomiting (PDQ®): Supportive care - Health Professional Information [NCI] - Nausea, Vomiting (Emesis), Constipation, and Bowel Obstruction in Advanced Cancer
FrequencyNausea and vomiting (emesis) (N&V) are common symptoms in patients with advanced cancer, occurring in approximately 21% to 68% of these patients.[1,2] The underlying pathophysiology and treatment differs somewhat from nausea related to radiation treatment or chemotherapy. Chronic nausea can significantly impair a patient's quality of life. Pathophysiology and CausesChronic nausea in the advanced cancer setting is often multifactorial in origin.[1,2,3] Medications, including some that are frequently prescribed in this setting—such as opioids, nonsteroidal anti-inflammatory drugs, and selective serotonin reuptake inhibitor (SSRI) antidepressants—may be responsible. In the case of opioids, nausea frequently resolves spontaneously a few days after initiation of treatment. In some cases, however, it may persist. Nausea resulting from the accumulation of active opioid metabolites (morphine-6-glucuronide) has been described, and patients with impaired renal function
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information
This cancer treatment information summary provides an overview of the prognosis,diagnosis,classification,and treatment of childhood acute myeloid (myelogenous) leukemia (AML) and other childhood myeloid malignancies. The National Cancer Institute provides the PDQ pediatric cancer treatment information summaries as a public service to increase the availability of evidence-based cancer ...
Lymphedema (PDQ®): Supportive care - Health Professional Information [NCI] - Changes to This Summary (06 / 30 / 2011)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.This summary is written and maintained by the PDQ Supportive and Palliative Care Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
Pituitary Tumors Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Pituitary Tumors
A pituitary tumor is a growth of abnormal cells in the tissues of the pituitary gland. Pituitary tumors form in the pituitary gland,a pea-sized organ in the center of the brain,just above the back of the nose. The pituitary gland is sometimes called the "master endocrine gland" because it makes hormones that affect the way many parts of the body work. It also controls hormones made by many ...
Genetics of Prostate Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Polymorphisms and Prostate Cancer Susceptibility
The advent of large-scale high-throughput genotyping capabilities has resulted in an explosion of association studies between particular genes or genomic regions and prostate cancer risk. It is difficult to assess the import of any individual study. Accordingly,this PDQ Genetics of Prostate Cancer information summary will not attempt to provide an encyclopedic review of all such studies. ...
Parathyroid Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Get More Information From NCI
Sources of further information about Parathyroid Cancer Treatment.
Non-Small Cell Lung Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - About This PDQ Summary
PURPOSE OF THIS SUMMARY This PDQ cancer information summary for health professionals provides comprehensive,peer-reviewed,evidence-based information about the treatment of non-small cell lung cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. REVIEWERS ...
Nausea and Vomiting (PDQ®): Supportive care - Patient Information [NCI] - Changes to This Summary (04 / 02 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Editorial changes were made to this summary.